Cargando…

Consistency and diagnostic accuracy of 4 assays in the detection of the total and free prostate-specific antigen

BACKGROUND: The lack of interchangeability among prostate-specific antigen (PSA) assays causes difficulties in clinical interpretation. The currently available mainstream assays for PSA were based on Western populations, but it is not clear whether these assays yield different results in prostate ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Lingyan, Yue, Daoyuan, Wang, Xu, Li, Huijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006006/ https://www.ncbi.nlm.nih.gov/pubmed/36915871 http://dx.doi.org/10.21037/tau-23-29

Ejemplares similares

A systematic review of the diagnostic accuracy of prostate specific antigen
por: Harvey, Philip, et al.
Publicado: (2009)

Screening for prostate cancer: a study on the free and total prostate specific antigen
por: Mediu, Ridvana, et al.
Publicado: (2021)

Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients
por: Merriel, Samuel W. D., et al.
Publicado: (2022)

Adding free to total prostate-specific antigen levels in trials of prostate cancer screening
por: Wald, N J, et al.
Publicado: (2000)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
por: Choi, Hoon, et al.
Publicado: (2013)

Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study
por: Wu, Bo, et al.
Publicado: (2023)

Utility of Free/Total Prostate Specific Antigen (f/t PSA) Ratio in Diagnosis of Prostate Carcinoma
por: Thakur, V., et al.
Publicado: (2004)

Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL: A meta-analysis
por: Huang, Yan, et al.
Publicado: (2018)

Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma
por: Duraker, N, et al.
Publicado: (2002)

Effect of Histological Inflammation on Total and Free Serum Prostate-Specific Antigen Values in Patients Without Clinically Detectable Prostate Cancer
por: Stimac, Goran, et al.
Publicado: (2014)

Potential diagnostic value of multiple indicators combined with total prostate-specific antigen in prostate cancer
por: Zhang, Qingxu, et al.
Publicado: (2023)

Diagnostic Accuracy of Prebiopsy Ga-68 PSMA PET/CT in Detecting Primary Prostate Carcinomas with Prostate-Specific Antigen <50 ng/ml
por: Chandra, Piyush, et al.
Publicado: (2020)

Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection
por: Yoneyama, Tohru, et al.
Publicado: (2019)

Toward a Prostate Specific Antigen-Based Prostate Cancer Diagnostic Assay: Preparation of Keyhole Limpet Hemocyanin -Conjugated Normal and Transformed Prostate Specific Antigen Fragments
por: Dudkin, Vadim Y., et al.
Publicado: (2008)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
por: Jung, Jin-Woo, et al.
Publicado: (2019)

Prostate-specific antigen testing accuracy in community practice
por: Hoffman, Richard M, et al.
Publicado: (2002)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)

The Diagnostic Accuracy of Prostate-Specific Antigen and Digital Rectal Examination in the Diagnosis of Prostate Cancer at the University of Benin Teaching Hospital
por: Ozah, Ehiremhen, et al.
Publicado: (2023)

An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen
por: Kammeijer, Guinevere S. M., et al.
Publicado: (2018)

Insights into the Mechanism of Bipolar Electrodeposition of Au Films and Its Application in Visual Detection of Prostate Specific Antigens
por: Zhao, Daoyuan, et al.
Publicado: (2023)

Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997)

The parallel lives of prostate specific antigen in cardiac troponin assays
por: Diamandis, Eleftherios P.
Publicado: (2023)

Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer
por: Wang, Xijuan, et al.
Publicado: (2017)

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies
por: Hiebert, Joanne, et al.
Publicado: (2022)

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Measles Virus-Specific IgM Antibodies
por: Hiebert, Joanne, et al.
Publicado: (2021)

Combining Prostate-Specific Antigen Parameters With Prostate Imaging Reporting and Data System Score Version 2.0 to Improve Its Diagnostic Accuracy
por: Baruah, Sasanka Kumar, et al.
Publicado: (2019)

Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma
por: Yin, Ming, et al.
Publicado: (2007)

Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate
por: Agnihotri, Shalini, et al.
Publicado: (2014)

The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
por: Flores-Fraile, María-Carmen, et al.
Publicado: (2020)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
por: Zou, Bing-Zi, et al.
Publicado: (2023)

Diagnostic Accuracy of Early Secretory Antigenic Target-6–Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube
por: Nemes, Elisa, et al.
Publicado: (2019)

Gold nanoparticle-based colorimetric method for the detection of prostate-specific antigen
por: Xia, Ning, et al.
Publicado: (2018)

Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy
por: Wang, Fu-Bo, et al.
Publicado: (2017)

Diagnostic Role of Prostate-Specific Membrane Antigen in Adrenocortical Carcinoma
por: Gu, Yulin, et al.
Publicado: (2019)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

An Ultra-Rapid Biosensory Point-of-Care (POC) Assay for Prostate-Specific Antigen (PSA) Detection in Human Serum
por: Mavrikou, Sophie, et al.
Publicado: (2018)

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
por: Lee, Dan Bee, et al.
Publicado: (2023)

Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone
por: SALIDO-GUADARRAMA, ALBERTO IVAN, et al.
Publicado: (2016)

Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities
por: Chung, Jae Hoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b4j0o2slf1sv7hhj8gkj3n8mj7